Latest from Premium

Market close: Power companies lift NZ sharemarket higher

The index ended the week on a positive note.

She was diagnosed with brain cancer, then wrote a rom-com about it

NYT: Author packs love, laughter and a harrowing real-life health ordeal into new book.

Inside look: Mowbrays' Zuru expands Chinese factory to make big confectionary push

Zuru's Henry Gordon talks about its plans to take on Kinder Surprise.

Inside Cathay Pacific's new Aria business-class suites

Cathay promises a "next level" flying experience with its upgraded business class.

Exclusive: Taiwanese Foreign Minister keen to “participate” in Aukus pillar 2

Pillar 2 of Aukus is getting crowded.

The symptoms of perimenopause – and six signs it’s nearing its end

Telegraph: Hormonal changes during perimenopause can start years before menopause.

'Dire' shortages, burnout fears: Stuff staff hit out as fresh cuts loom

Worker frustrations boil over at Stuff as more staff face job cuts.

Four economic truths that explain the US’ bizarre election

Financial Times: A trip to America’s No 3 shopping mall offers some strange answers.

Alex Powell: What's at stake as Lawson returns to F1

OPINION: The Kiwi has six Grands Prix to prove he belongs on the grid next year.

Matthew Hooton: Time for a 12.5% company tax rate?

OPINION: Glad-handing and dating services will never attract the major investment we need.

Cheaper and more potent: New research on tensions in medicinal cannabis market

Legal cannabis overseas has led to health problems among teenagers. Is that NZ's future?

How Kamala Harris worked her way to the top – by those who knew her

Times: 'This woman had tremendous competence and poise. She was very commanding.'

Stock Takes: Investors look to 2025, Rocket Lab shoots higher

The sharemarket has opted to ignore good news on the inflation and interest rates front.

Letters: Healthcare risks being lost in translation; Wgtn’s tone-deaf council

OPINION: 'Sadly the beleaguered mayor and council are tone-deaf to calls for changing.'

Fonterra's owners need much more info on why consumer business should go: adviser

But they may not get it until well into next year.

The 3-minute orgasm: A Kiwi scientist on reversing libido loss at menopause

Dr Iona Weir talks about putting her own product to the test.